Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Prepaid Assets (2022 - 2025)

Corvus Pharmaceuticals (CRVS) has 4 years of Prepaid Assets data on record, last reported at $1.2 million in Q3 2025.

  • For Q3 2025, Prepaid Assets changed N/A year-over-year to $1.2 million; the TTM value through Sep 2025 reached $1.2 million, changed N/A, while the annual FY2024 figure was $308000.0, 60.56% down from the prior year.
  • Prepaid Assets reached $1.2 million in Q3 2025 per CRVS's latest filing, up from $308000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $1.2 million in Q3 2025 and bottomed at $51000.0 in Q1 2024.
  • Average Prepaid Assets over 4 years is $457500.0, with a median of $280000.0 recorded in 2022.
  • Peak YoY movement for Prepaid Assets: skyrocketed 209.92% in 2023, then crashed 60.56% in 2024.
  • A 4-year view of Prepaid Assets shows it stood at $252000.0 in 2022, then surged by 209.92% to $781000.0 in 2023, then plummeted by 60.56% to $308000.0 in 2024, then surged by 297.08% to $1.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $1.2 million in Q3 2025, $308000.0 in Q4 2024, and $51000.0 in Q1 2024.